The Impending Global Challenge of Antimicrobial Resistance: A Call for Urgent Action
DOI:
https://doi.org/10.47203/IJCH.2024.v36i05.001Abstract
Antimicrobial resistance (AMR) is a critical global health issue driven by antibiotic misuse and overuse in various sectors, leading to the emergence of resistant microorganisms and represents an impending pandemic. Against the backdrop of COVID-19 pandemic, conflicts, and the escalating impact of anthropogenic climate change, the emergence and rapid escalation of antimicrobial resistance (AMR) represent one of the most significant and imminent global public health threats of the 21st century.(1) As bacteria, viruses, fungi, and parasites increasingly evolve resistance to drugs that once treated infections effectively, the ‘superbugs’ such as Methicillin-resistant Staphylococcus aureus (MRSA) and extremely drug-resistant tuberculosis, bacteria that are difficult to treat have emerged. This has brought humanity to the brink of a post-antibiotic era, where re-emergence of common infections is being noted. With resistance on the rise, surgical procedures like organ transplants and cesarean sections, cancer treatments where antibiotics are crucial, and management of life-threatening infectious diseases such as pneumonia, TB, HIV, and malaria are at risk of becoming dangerous due to the high potential for untreatable infections. (2)
Downloads
References
Anna Davies, Gregory Hooks, Janelle Knox-Hayes, Raoul S Liévanos, Risk scapes and the socio-spatial challenges of climate change, Cambridge J Regions, Economy and Society 2020;13(2):197-213.
Jamrozik E, Selgelid M, editors. Ethics and Drug Resistance: Collective Responsibility for Global Public Health [Internet]. Cham (CH): Springer; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK566843/ [Last accessed on 05 Oct 2024]
World Health Organization (WHO), Antimicrobial resistance; Key facts; 21 November 2023; WHO. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance [Last accessed on 05 Oct 2024]
Murray, Christopher JL Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis; The Lancet 2022;399(10325):629-55.
Velazquez-Meza ME, Galarde-López M, Carrillo-Quiróz B, & Alpuche-Aranda CM. Antimicrobial resistance: One Health approach. Vet World. 2022;15(3):743–49.
Iskandar K, Molinier L, Hallit S, Sartelli M, Hardcastle TC, Haque M, et al. Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture. Antimicrob Resist Infect Control. 2021;10(1):63-65
Majumder MAA, Rahman S, Cohall D, Bharatha A, Singh K, Haque M, & Gittens-St Hilaire M. Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health. Infection Drug Resistance 2020;13:4713–38.
Compiled report of National Expert Consultations for developing National Action Plan on Antimicrobial Resistance 2.0 https://ncdc.mohfw.gov.in/wp-content/uploads/2024/05/Compiled-report-of-National-Expert-Consultations-for-developing-National-Action-Plan-on-Antimicrobial-Resistance-2.0.pdf [Last accessed on 05 Oct 2024]
Mathew P, Thomas SA, & Chandy SJ. The role of Schedule H1 and Red Line campaign in improving antibiotic use in India. J Family Med Prim Care 2022;11(6):2656–61.
Published
How to Cite
License
Copyright (c) 2024 Purushottam Giri, Aditi Aikat
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.